evaluate the pharmaceuticals company saxenda on glp-1 and insurance providers Perspectives from employers costs issues associated with covering agonists for weight loss GLP-1 Agonists Weight Loss Drugs

Description

Bot Verification Verifying that you are not a robot...

We changed pharmacy vendor, now you cant get it unless you have had a history of diabetes. Senior Benefits Manager, large manufacturer Weve never offered it for weight loss, and it is still one of our top three prescriptions spends every year. HR Professional, large manufacturer We dont allow GLP-1s for weight loss In our type 2 diabetes population, 50% are utilizing the GLP-1s, so we are now excluding them for anything except type 2 diabetes [to manage costs]. Director of Benefits, large manufacturer The future of GLP-1 drug prices Employers are also recognizing that the price paid by employers for GLP-1 drugs are sometimes higher than online direct-to-consumer prices reflecting manufacturer discounts

What is the risk of muscle loss during GLP-1 research

HF is closely related to cardiometabolic diseases such as diabetes, obesity and chronic kidney disease, and strategies that address most or all these intertwined conditions are desirable